therapy / therapeutics

CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 76 agents in development for CRC, 4 of which are in late-phase...